Stockreport

Canaccord Lowers its Price Target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and Maintains a Buy Rating [Yahoo! Finance]

TriSalus Life Sciences, Inc.  (TLSI) 
PDF TriSalus Life Sciences, Inc. (NASDAQ: TLSI is among the 11 Fastest Growing Penny Stocks to Buy Right Now Canaccord Lowers its Price Target on TriSalus Life Sciences, [Read more]